Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Superiority Trial Evaluating the Benefit of Dematerialized Information Media for Patients With Advanced Sarcomas Receiving Systemic Treatment for Metastatic or Locally Advanced Disease.

NCT06211257 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT06211257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06211257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Superiority Trial Evaluating the Benefit of Dematerialized Information Media for Patients With Advanced Sarcomas Receiving Systemic Treatment for Metastatic or Locally Advanced Disease.
Lead sponsor
Centre Oscar Lambret
Phase
Not applicable
Overall status
Recruiting
Start date
May 29, 2024
Completion date
April 30, 2030
Enrollment
377 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced soft tissue sarcoma, sarcoma metastatic